BetterScholar BetterScholar
11
Role
Title
Level Year L/R
🐜 Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons.
15 auth. R. Bogers, W. Bemelmans, R. Hoogenveen, H. Boshuizen, M. Woodward, P. Knekt, R. V. van Dam, F. Hu, T. Visscher, A. Menotti, ... R. Thorpe, K. Jamrozik, Susanna Calling, B. Strand, M. Shipley
9 2007
9
🐜
🐜 Lifetime Medical Costs of Obesity: Prevention No Cure for Increasing Health Expenditure
9 auth. P. van Baal, J. Polder, G. Ardine De Wit, R. Hoogenveen, T. Feenstra, H. Boshuizen, ... P. Engelfriet, W. Brouwer, A. Prentice
8 2008
8
🐜
🐬 The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands.
T. Feenstra, M. L. L. Genugten, R. Hoogenveen, E. Wouters, M. R. MΓΆlken
8 2001
8
🐬
🐬 Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach
M. Hoogendoorn, R. Hoogenveen, M. R. MΓΆlken, J. Vestbo, J. Vestbo, T. Feenstra
7 2010
7
🐬
🐬 Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.
T. Feenstra, Heleen H. Hamberg-van Reenen, R. Hoogenveen, M. R. Rutten-van MΓΆlken
7 2005
7
🐬
🐬 Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD
M. Hoogendoorn, T. Feenstra, R. Hoogenveen, M. R. Rutten-van MΓΆlken
7 2010
7
🐬
🐬 Lifestyle Interventions Are Cost-Effective in People With Different Levels of Diabetes Risk
M. A. Jacobs-van der Bruggen, G. Bos, W. Bemelmans, R. Hoogenveen, S. Vijgen, C. Baan
7 2007
7
🐬
🐜 A dynamic population model of disease progression in COPD
7 auth. M. Hoogendoorn, M. R. MΓΆlken, R. Hoogenveen, Ml van Genugten, A. Buist, E. Wouters, ... T. Feenstra
7 2005
7
🐜
🐬 Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a 'perfect' cost-utility ratio.
P. van Baal, T. Feenstra, R. Hoogenveen, G. A. D. de Wit, W. Brouwer
6 2007
6
🐬
🐬 Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a 'perfect' cost-utility ratio.
P. van Baal, T. Feenstra, R. Hoogenveen, G. A. D. de Wit, W. Brouwer
6 2007
6
🐬
🐬 Disability weights for comorbidity and their influence on Health-adjusted Life Expectancy
P. van Baal, N. Hoeymans, R. Hoogenveen, Ardine de Wit, G. Westert
6 2006
6
🐬